Artificial Placenta Technologies and Maternity Leave in European Labor Law
By Victoria Hooton and Elizabeth Chloe Romanis The emergent Artificial Amnion and Placenta Technology (AAPT) provides an illuminating example of
Read MoreBy Victoria Hooton and Elizabeth Chloe Romanis The emergent Artificial Amnion and Placenta Technology (AAPT) provides an illuminating example of
Read MoreThe U.S. Food & Drug Administration (FDA) issued final guidance (Final Guidance) regarding informed consent titled “Informed Consent: Guidance for
Read MoreBy Michelle Weldon-Johns An increasing number of people in the UK undergo assisted reproductive technology (ART) treatments annually to conceive
Read MoreThe Health Resources and Services Administration (HRSA) Uninsured Program (UIP), which reimbursed providers for provision of COVID-19 related services to
Read MoreBy Kathleen (Katie) Hammond We have seen a growing trend in recent years of companies covering some, or all, of
Read MoreIn the third edition of our blog series on decentralized clinical trials (DCTs), we address U.S. Food and Drug Administration’s (FDA)
Read MoreBy Nofar Yakovi Gan-Or As Israeli law has adapted to new reproductive realities, it has relied on more “traditional” familial
Read MoreSpecial thanks to summer associate Sheridan Organ for her contributions to this article. On May 4, 2023, the Florida Senate
Read MoreBy Lucas Taylor Surrogacy, the practice in which one party (the surrogate) gestates a fetus on behalf of another pair/person
Read MoreOn July 13, the Centers for Medicare & Medicaid Services (CMS) released its annual Proposed Rule updating the Medicare Physician
Read More